Schiff Center for Liver Diseases/University of Miami — Miami, Florida

Public research footprint of Schiff Center for Liver Diseases/University of Miami, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Nonalcoholic Steatohepatitis · Primary Biliary Cholangitis · Primary Sclerosing Cholangitis · HIV-1-infection

Recently updated registry entries

NCT04526665 — Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) (Active Not Recruiting)
NCT06447168 — A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in… (Recruiting)
NCT05627362 — A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Schiff Center for Liver Diseases/University of Miami?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.